Man Bitten by Snakes 200 Times May Help Create New Antivenom
By I. Edwards HealthDay Reporter
MONDAY, May 5, 2025 — Tim Friede has survived hundreds of snakebites — on purpose. For nearly two decades, he let some of the world’s most dangerous snakes sink their fangs into his arms, all for science.
Now, his bold experiment could potentially help save thousands of lives.
Friede, 57, from Wisconsin, has spent nearly 20 years injecting himself with snake venom to build immunity.
His work may now help solve a major global health problem: Each year, venomous snakes bite up to 2.7 million people, causing an estimated 120,000 deaths and 400,000 injuries, The New York Times reported.
In a two-minute video, Friede calmly allows two deadly snakes — a black mamba and a taipan — to bite his arms. Despite bleeding from both arms, he smiles and says, “Thanks for watching.”
Researchers have discovered two powerful antibodies in Friede’s blood that, when combined with a drug called varespladib, protected mice from the venom of 19 snake species.
This is a major leap forward: Current antivenoms typically only work against one or a few closely related snake species.
“I’m really proud that I can do something in life for humanity, to make a difference for people that are 8,000 miles away, that I’m never going to meet, never going to talk to, never going to see, probably,” Friede told The Times.
He began experimenting in the early 2000s, sometimes housing up to 60 venomous snakes in his basement. His passion nearly cost him his life in 2001, when he let two cobras bite him and ended up in a coma for four days. That experience pushed him to become more careful and precise in his work.
Jacob Glanville, founder of San Francisco-based vaccine developer Centivax and lead author of the study, met Friede in 2017. Working with Peter Kwong, a Columbia University vaccine researcher, Glanville’s team isolated the antibodies and tested them in the mice.
One antibody protected against six snake species. When combined with the second antibody, mice were protected from 13 snake venoms and partly shielded against six more.
Nicholas Casewell, a researcher at the Liverpool School of Tropical Medicine in England, told The Times that cocktails of antitoxins may neutralize the venom of many species.
Traditional antivenom is made by injecting animals like horses or sheep with small amounts of venom, then collecting the antibodies they produce. But this process is outdated and pretty much only works on specific snakes. Many antivenoms can also cause dangerous allergic shock in some people because of the proteins from the mammal.
The hope? Combining human-made antibodies with drugs like varespladib can neutralize a wider range of snake venoms with fewer side effects.
Next, researchers plan to test the treatment in dogs bitten by snakes in Australia, The Times said in a recently published report. Australia is home to some of the world's deadliest snakes.
Friede says his snakebite days are behind him. His last bite was in 2018.
“Well, that’s it, enough is enough,” Friede said.
He misses the snakes. But, “I’ll probably get back into it in the future,” he said. “But for right now, I’m happy where things are at.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-06 06:00
Read more

- Advanced Biological Age Linked to Increased Risk for Incident Dementia
- Trump Administration Plans Ban on More Synthetic Food Dyes
- Vaccine Panel Urges More Protection Against RSV, Meningitis and Chikungunya
- Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
- FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar to Avastin
- Human Fertility Levels Need To Be Higher To Avoid Extinction
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions